Stem Cell Medical Market Will Reach 80 Billion U.s. Dollars In 2015 - Stem Cells, Medical Care,

Stem Cells Research and application of biomedical technology in recent years a hot topic

. The last ten years, studies have found that cord blood has become an important source of hematopoietic stem cells. Umbilical cord blood stem cells broad industrial prospects have attracted the attention of many social capital.

"Our cord blood stem cell bank storage capacity of 300 000 copies total, the current auto- Storage About 8 million, more than 5,000 copies of the public store. "Recently, Concord stem cell gene Project Co., Ltd. (hereinafter referred to as "Union Stem Cell Company") related to marketing head, said in an interview, "As of now, we have accumulated output value of 512 million yuan, profits and taxes 120 million yuan."

Concord stem cells located in Tianjin New Technology Industrial Park, by the listed company Wangchunhua Chinese Academy of Medical Sciences and Peking Union Medical College Institute of Hematology Blood diseases Hospital Common Investment Building, former investment holding of 57% the latter accounted for 43% of technology shares, its main business of resource conservation for the stem cells, monoclonal antibodies and gene Chip R & D, production, sales and clinical application of stem cells, has the world's largest stem cell bank one?? Tianjin cord blood stem cell bank, the library is the first inspection by the Ministry of Health of cord blood hematopoietic stem cell bank is Wangchunhua core asset. Public disclosure of information, 1 September 2007, Concord stem cell company achieved operating income of 150 million yuan, 107 million the same period the previous year increased by 43 million yuan, up 40.19 percent; to achieve net profit of 31.91 million yuan, more than 19.61 million yuan over the same period last year increased by 12.3 million yuan, up 62.72 percent.

"Our sales revenue a year from 6% to 8% to research and development effort to create the stem cell, gene, protein biotechnology industry platform." Cord blood stem cell bank in Tianjin, director Paul Chiu told reporters expensive.

Reporter has learned that the current total of Beijing, Tianjin, Shanghai, Guangdong Province , Sichuan, Shandong Province, six cord blood bank set up by the Ministry of Health approval and adoption of acceptance around the local health bureau. Cord blood bank CEO Summit in Beijing told reporters in Beijing cord blood stem cell bank was established in 1996 by Beijing Jia Chen Hong Biotechnology Co., Ltd. (hereinafter referred to as "Hong Jia Chen") and the Joint Institute of Hematology, Peking University set of 4 million copies are currently stored umbilical cord blood hematopoietic stem cells, including donations, public storage and the storage capacity of individuals paid from the body ratio of 1:3.

"We are now building a building area of 10,000 square meters of new libraries, storage capacity up to 30 million. Estimated" 51 "can move in after." Peak told reporters.

Learned, good Chen Hong Hong Kong Business Listed companies are majority owned subsidiary of Golden Meditech. "Golden Meditech cord blood bank in Beijing reached 300 million yuan of total investment is about profit yet. But we stress is the cause of the development prospects of the clinical value of umbilical cord blood invaluable." Peak told reporters. Umbilical cord blood can be used to treat various blood disorders and Immunity Diseases, including malignant blood system Cancer (Such as acute leukemia, chronic leukemia, multiple myeloma, bone marrow dysplasia syndrome, lymphoma, etc.), hemoglobin disease (such as thalassemia), bone marrow failure (such as aplastic anemia), congenital metabolic diseases , congenital immunodeficiency disorders, autoimmune disorders, certain solid tumors (such as small cell Lung Cancer , Neuroblastoma, ovarian cancer, etc.), and treatment of types of diseases it can still increasing.

Experts point out that cord blood stem cell storage is only the initial stage of the industry, the future industrial development is the repository of stem cells to be extended on the basis of the project include genetic medicine, genetic diagnosis Reagent , Stem cell products, and stem cell transplantation. According to reports, Concord stem cell R & D of "cord blood stem cell products and amplification products" have been key new products in Tianjin Certificate .

Studies have indicated that by 2015, the global stem cell potential market size of medical about 80 billion U.S. dollars. "Despite the stem cell industry is far from the arrival of spring, but we are very optimistic about its prospects." Concorde stem cells related to the marketing department official said.

by: gaga

POST COMMENT

Im Elite Scam: Why Shouldn't You Buy Alex Sheldon and George Brown's IMElite Training Course Melaleuca Review - Updated Report On Melaleuca Complaints & Scam Rumors 5 Qualities For Affiliate Marketing Web Hosting Design: How To Profit From Free Or Paid Web Hosting Site Setting Up Your Affiliate Marketing System Cheat Your Way Thin Scam PPI: A Scam or A Reality? BidSauce Review - The Real Deal Or A Scam? Other Notable Common Affiliate Marketing Mistakes Global Insulin Market Set For Stupendous Upsurge A Day In The Life Of An Affiliate Marketer Affiliate Marketing Affiliate Marketing And Pay Per Click